CAR-T Therapy Global Market Report 2024

CAR-T Therapy Global Market Report 2024 – By Type (Monotherapy, Combination Therapy), By Target Antigen (CD19, CD22, BCMA, Other Target Antigens), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Name: CAR-T Therapy Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

CAR-T Therapy Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

CAR-T Therapy Pipeline Analysis Market Definition

The chimeric antigen receptor -T therapy is a type of immunotherapy in which T-cells are taken from the patient’s blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as the chimeric antigen receptor (CAR), attaches to a specific protein on a patient’s cancer cells. The infused cells multiply and prevail in the patient’s body as living drugs.

The main types of chimeric antigen receptor -T therapy is monotherapy and combination therapy. Monotherapy is used in the treatment of any disease with a single drug. The target antigens involved are CD19, CD22, and others that are used in various applications such as acute lymphoblastic leukemia, diffuse large b-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, multiple myeloma, and others.

CAR-T Therapy Pipeline Analysis Market Segmentation

The car-t therapy pipeline analysis market covered in this report is segmented –

1) By Type: Monotherapy, Combination Therapy

2) By Target Antigen: CD19, CD22, BCMA, Other Target Antigens

3) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications

Global CAR-T Therapy Pipeline Analysis Market Size 2023 to 2028: Graph

CAR-T Therapy Pipeline Analysis Market Size 2024 And Growth Rate

The car-t therapy pipeline analysis market size has grown rapidly in recent years. It will grow from $2.15 billion in 2023 to $2.55 billion in 2024 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to increases in healthcare expenditure, increase in pharmaceutical r&d expenditure and advances in drug discovery.

CAR-T Therapy Pipeline Analysis Market Growth Forecast

The car-t therapy pipeline analysis market size is expected to see rapid growth in the next few years. It will grow to $4.74 billion in 2028 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to increase in blood cancer incidence rate, rise in healthcare expenditure, strong pipeline of drugs and rising focus on car-t therapy. Major trends in the forecast period include investing in the r&d for creating remodeled car-t therapy to avoid neurological side-effects, creating off-the-shelf allogeneic car-t therapy for advanced cancer treatment, manufacturing next-generation car t cells for improved treatment of high-grade glioma, investing in ai and machine learning solutions to optimize future car-t therapy, carrying out strategic collaborations to boost innovations, collaborating or acquiring competitor companies to expand car-t therapy portfolio, and investing in the car-t therapy to make it more effective.

Book your 30 minutes free consultation with our research experts

CAR-T Therapy Pipeline Analysis Market Driver: Financial Support Driving Growth In The Car-T Therapy Market

The CAR-T therapy market is driven by the increasing financial support provided by different organizations to promote the development and consumption of CAR-T therapy. The government and non-government organizations provide financial support to the companies in the CAR-T therapy market for research and development and the patients for their treatment of acute lymphoblastic leukemia (ALL). For instance, in December 2021, the University of California San Diego School of Medicine (CA, USA) was granted a funding of US$ 4.1 million for the development of novel chimeric antigen receptor (CAR-T) cell therapy. The grant was awarded by California Institute for Regenerative Medicine (CIRM; CA, USA) governing board. The financial support provided by different organizations towards CAR-T therapy positively drives the growth of the CAR-T therapy market.

CAR-T Therapy Pipeline Analysis Market Driver: Increasing Cancer Prevalence Driving Growth In The Car-T Therapy Market

The rising prevalence of cancer is expected to propel the growth of the CAR-T therapy market going forward. The rising prevalence of cancer refers to the increasing number of diagnosed cases of cancer within a specific population or region over a given period of time. The rising prevalence of cancer has driven research and investment in cancer therapies, including cellular immunotherapies. These treatments represent a significant advancement in the field of oncology and are particularly relevant for addressing the needs of cancer patients. For instance, in 2021, according to American cancer society journal, estimated numbers of new cancer cases and deaths in 2021 (In 2021, there will likely be 608,570 cancer deaths in the United States and 1.9 million new cases of cancer diagnosed). Therefore, the rising prevalence of cancer is driving the growth of the CAR-T therapy market.

Global CAR-T Therapy Pipeline Analysis Market Major Players

Major companies operating in the car-t therapy pipeline analysis market report are Gilead Sciences, Novartis AG, Biocon, Gracell Biotechnology Ltd, Aeon Therapeutics, CARsgen Therapeutics, Daiichi Sankyo, Otsuka Pharmaceutical, Ono Pharmaceutical, Japan Tissue Engineering, Nipro Corporation, Takeda Pharmaceutical Company, Astellas Pharma, Innovative Cellular Therapeutics, Cellular Biomedicine Group, PersonGen Biomedicine, Hebei Senlang Biotech, Adaptimmune(UK), Autolus Therapeutics, BioNTech, Cellectis, Celyad, Crescendo Biologics, GammaDelta Therapeutics, Immatics, Biocad, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Amgen, AstraZeneca, Bayer AG, Merck, Pfizer, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio Amgen, Regen BioPharma, OncoSec Medical Incorporated, Precision BioSciences, Bellicum, Sandoz AG, GlaxoSmithKline plc, Elekta, SudairPharma, Janssen, Aspen, Adcock Ingram

Global CAR-T Therapy Pipeline Analysis Market Restraint: Limitations On Car-T Therapy Hindering Market Growth

The limitations on the application of CAR-T therapy limit the growth of the market. The limitations of CAR-T therapy include its failure to treat other types of cancer, side effects, and the high cost of treatment. CAR-T therapy is widely used as a treatment for a particular type of blood cancer and fails to treat other types of cancers such as lung cancer or breast cancer. Further, in many cases, the application of CAR-T therapy results in cytokine release syndrome (CRS). CRS is a severe flu-like condition causing high fever, nausea, chills, headache, rash, and troubled breathing. Further, the high cost limits the growth of the market. According to a report from Kaiser Health News, the per-patient cost of CAR-T cell therapy was more than $1 million in 2021. Thus, the growth of CAR-T therapy is restricted by the various limitations on the application of CAR-T therapy.

Global CAR-T Therapy Pipeline Analysis Market Trend: Clinical Trials And Advancements In Car-T Therapy For Multiple Myeloma

The companies in the CAR-T therapy market are conducting clinical trials to assess the ability of CAR-T therapy to treat multiple myeloma. Multiple myeloma is a type of white blood cell cancer where the cancer cells accumulate in the bone marrow and surrounds the healthy blood cells. CAR-T therapy is being tested as a treatment for multiple myeloma. CAR-T cells are modified to target the multiple myeloma causing cells to treat the relapsed or refractory multiple myeloma (RRMM). For instance, in December 2021, Novartis announced the introduction of T-Charge™, the company’s next-generation CAR-T platform that will serve as the foundation for various new investigational CAR-T cell therapies in the Novartis pipeline. The product was in the early clinical stage (Phase I).

Global CAR-T Therapy Pipeline Analysis Market Trend: Innovation In Car-T Therapy Market: Introduction Of Biocentriq By Terumo Blood And Cell Technologies

Major companies operating in the CAR-T cell therapies market are innovating new products such as BioCentriq to increase their profitability in the market. BioCentriq serves as a valuable resource for organizations involved in the development, manufacturing, and research of cell and gene therapies, facilitating advancements in the field and ultimately improving patient care. For instance, in October 2023, Terumo Blood and Cell Technologies, a Japan-based a medical technology company, launched the BioCentriq to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms, In collaboration with Terumo BCT, BioCentriq aims to pioneer publicly accessible data on rapid CAR-T cell manufacturing using the Quantum Flex and Finia platforms. This innovative trial seeks to showcase the efficient production of high-quality CAR-T cells, leveraging the seamless integration of Terumo BCT's technology and BioCentriq's process expertise for streamlined, GMP-translatable workflows.

CAR-T Therapy Pipeline Analysis Market Merger And Acquisition: Astellas' Strategic Acquisition Of Iveric Bio Expanding Ocular Healthcare Capabilities

In July 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, acquired Iveric Bio for $5.9 billion. With this acquisition, Astellas is better positioned to serve patients with ocular illnesses at high risk of going blind. The chance to establish a top-tier organization with Iveric Bio's ophthalmology knowledge and capabilities and Astellas' global resources is exceptional and has the potential to help patients worldwide who suffer from blinding retinal illnesses, including GA. The transaction was subject to Iveric Bio's stockholders' approval and other usual closing requirements, such as obtaining necessary regulatory approvals. Iveric Bio is a US-based Biotech company.

Regional Analysis For The Global CAR-T Therapy Pipeline Analysis Market

North America was the largest region in the CAR-t therapy market in 2023. Western Europe was the second-largest region in the global CAR-T therapy market share. The regions covered in the car-t therapy pipeline analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the car-t therapy pipeline analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The chimeric antigen receptor -T therapy market includes revenues earned by CAR-T therapy products and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chimeric antigen receptor -T therapy market research report is one of a series of new reports from The Business Research Company that provides chimeric antigen receptor -T therapy market statistics, including chimeric antigen receptor -T therapy industry global market size, regional shares, competitors with a chimeric antigen receptor -T therapy market share, detailed chimeric antigen receptor -T therapy market segments, market trends and opportunities, and any further data you may need to thrive in the chimeric antigen receptor -T therapy industry. This chimeric antigen receptor -T therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

CAR-T Therapy Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$2.55 billion
Revenue Forecast In 2033	$4.74 billion
Growth Rate	CAGR of 16.7% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Type: Monotherapy, Combination Therapy 2) By Target Antigen: CD19, CD22, BCMA, Other Target Antigens 3) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Gilead Sciences; Novartis AG; Biocon; Gracell Biotechnology Ltd; Aeon Therapeutics; CARsgen Therapeutics; Daiichi Sankyo; Otsuka Pharmaceutical; Ono Pharmaceutical; Japan Tissue Engineering; Nipro Corporation; Takeda Pharmaceutical Company; Astellas Pharma; Innovative Cellular Therapeutics; Cellular Biomedicine Group; PersonGen Biomedicine; Hebei Senlang Biotech; Adaptimmune(UK); Autolus Therapeutics; BioNTech; Cellectis; Celyad; Crescendo Biologics; GammaDelta Therapeutics; Immatics; Biocad; Celgene Corporation; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Eli Lilly and Company; Amgen; AstraZeneca; Bayer AG; Merck; Pfizer; Juno Therapeutics; Allogene Therapeutics; Bluebird Bio Amgen; Regen BioPharma; OncoSec Medical Incorporated; Precision BioSciences; Bellicum; Sandoz AG; GlaxoSmithKline plc; Elekta; SudairPharma; Janssen; Aspen; Adcock Ingram
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. CAR-T Therapy Market Characteristics

3. CAR-T Therapy Market Trends And Strategies

4. CAR-T Therapy Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global CAR-T Therapy Market Size and Growth

5.1. Global CAR-T Therapy Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global CAR-T Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global CAR-T Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. CAR-T Therapy Market Segmentation

6.1. Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Monotherapy

Combination Therapy

6.2. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

CD19

CD22

Other Target Antigens

6.3. Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Acute Lymphoblastic Leukemia

Diffuse Large B-Cell Lymphoma

Follicular Lymphoma

Chronic Lymphocytic Leukemia

Multiple Myeloma

Other Applications

7. CAR-T Therapy Market Regional And Country Analysis

7.1. Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific CAR-T Therapy Market

8.1. Asia-Pacific CAR-T Therapy Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China CAR-T Therapy Market

9.1. China CAR-T Therapy Market Overview

9.2. China CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India CAR-T Therapy Market

10.1. India CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan CAR-T Therapy Market

11.1. Japan CAR-T Therapy Market Overview

11.2. Japan CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia CAR-T Therapy Market

12.1. Australia CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia CAR-T Therapy Market

13.1. Indonesia CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea CAR-T Therapy Market

14.1. South Korea CAR-T Therapy Market Overview

14.2. South Korea CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe CAR-T Therapy Market

15.1. Western Europe CAR-T Therapy Market Overview

15.2. Western Europe CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK CAR-T Therapy Market

16.1. UK CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany CAR-T Therapy Market

17.1. Germany CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France CAR-T Therapy Market

18.1. France CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy CAR-T Therapy Market

19.1. Italy CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain CAR-T Therapy Market

20.1. Spain CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe CAR-T Therapy Market

21.1. Eastern Europe CAR-T Therapy Market Overview

21.2. Eastern Europe CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia CAR-T Therapy Market

22.1. Russia CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America CAR-T Therapy Market

23.1. North America CAR-T Therapy Market Overview

23.2. North America CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA CAR-T Therapy Market

24.1. USA CAR-T Therapy Market Overview

24.2. USA CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada CAR-T Therapy Market

25.1. Canada CAR-T Therapy Market Overview

25.2. Canada CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America CAR-T Therapy Market

26.1. South America CAR-T Therapy Market Overview

26.2. South America CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil CAR-T Therapy Market

27.1. Brazil CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East CAR-T Therapy Market

28.1. Middle East CAR-T Therapy Market Overview

28.2. Middle East CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa CAR-T Therapy Market

29.1. Africa CAR-T Therapy Market Overview

29.2. Africa CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. CAR-T Therapy Market Competitive Landscape And Company Profiles

30.1. CAR-T Therapy Market Competitive Landscape

30.2. CAR-T Therapy Market Company Profiles

30.2.1. Gilead Sciences

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Novartis AG

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Biocon

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Gracell Biotechnology Ltd

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Aeon Therapeutics

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. CAR-T Therapy Market Other Major And Innovative Companies

31.1. CARsgen Therapeutics

31.2. Daiichi Sankyo

31.3. Otsuka Pharmaceutical

31.4. Ono Pharmaceutical

31.5. Japan Tissue Engineering

31.6. Nipro Corporation

31.7. Takeda Pharmaceutical Company

31.8. Astellas Pharma

31.9. Innovative Cellular Therapeutics

31.10. Cellular Biomedicine Group

31.11. PersonGen Biomedicine

31.12. Hebei Senlang Biotech

31.13. Adaptimmune(UK)

31.14. Autolus Therapeutics

31.15. BioNTech

32. Global CAR-T Therapy Market Competitive Benchmarking

33. Global CAR-T Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The CAR-T Therapy Market

35. CAR-T Therapy Market Future Outlook and Potential Analysis

35.1 CAR-T Therapy Market In 2028 - Countries Offering Most New Opportunities

35.2 CAR-T Therapy Market In 2028 - Segments Offering Most New Opportunities

35.3 CAR-T Therapy Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Gilead Sciences Financial Performance

Table 75: Novartis AG Financial Performance

Table 76: Biocon Financial Performance

Table 77: Gracell Biotechnology Ltd Financial Performance

Table 78: Aeon Therapeutics Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Gilead Sciences Financial Performance

Figure 75: Novartis AG Financial Performance

Figure 76: Biocon Financial Performance

Figure 77: Gracell Biotechnology Ltd Financial Performance

Figure 78: Aeon Therapeutics Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the anti-parkinson drugs market research report 2022 with industry size, share, segments and market growth

Electrophysiology Devices And Equipment Global Market Report 2024 – By Product Type (Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Lab Systems), By Monitoring Device Type (Electrocardiograph (ECG), Electroencephalograph (EEG), Electrocorticograph (ECoG), Electromyograph (EMG), Electroretinograph (ERG), Electrooculograph (EOG), Holter Monitoring Devices, X-Ray Systems, Imaging and 3D Mapping Systems, Diagnostic Electrophysiology Catheters, By Indication Analysis (Atrioventricular Nodal Reentry Tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), Atrial Flutter, Atrial Fibrillation), By End-Users (Hospitals, Diagnostic centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Bioinformatics Global Market Report 2024 – By Products and Services (Knowledge Management Tools, Data Analysis Platforms, Services), By Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatics, Genomics, Other Applications), By End Users (Pharmaceutics, Animal Study, Agriculture, Forensic Science, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Stem Cell/Cord Blood Banking Global Market Report 2024 – By Cell Type (Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells), By Service (Collection, Processing, Analysis, Storage), By Bank Type (Public, Private), By Application (Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Analytical Laboratory Instrument Global Market Report 2024 – By Type (Element Analysis, Separation Analysis, Molecular Analysis, Other Types), By Application (Research, Clinical, Diagnostic, Other Applications), By End-User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Biotechnology, Other End-users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Genomics Global Market Report 2024 – By Product Type (Instrument (Including Systems, Service Contract And Software), Reagents (Including Reagents And Consumables)), By Process (Cell Isolation, Sample Preparation, Genomic Analysis), By End User (Academic Institutes, Biopharmaceutical Companies, Clinical Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024 – By Product (Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants), By Procedure Type (Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types), By End-User (Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Antiemetics And Antinauseants Global Market Report 2024 – By Drug (Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types), By Application (Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types), By End Users (Hospital, Medical Center, Clinic, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Generic Pharmaceuticals Global Market Report 2024 – By Type (Biosimilars, Generics), By Drug Delivery (Oral, Injectables, Dermal/Topical, Inhaled), By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Biosimilars, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the CAR-T therapy pipeline analysis market?

How will the CAR-T therapy pipeline analysis market drivers and restraints affect the CAR-T therapy pipeline analysis market dynamics? What forces will shape the CAR-T therapy pipeline analysis industry going forward?

The CAR-T therapy pipeline analysis market major growth driver - Financial Support Driving Growth In The Car-T Therapy Market. For further insights on the CAR-T therapy pipeline analysis market, request a sample here

What is the forecast market size or the forecast market value of the CAR-T therapy pipeline analysis market?

The CAR-T therapy pipeline analysis market size has grown rapidly in recent years. It will grow from $2.15 billion in 2023 to $2.55 billion in 2024 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to increases in healthcare expenditure, increase in pharmaceutical r&d expenditure and advances in drug discovery. The CAR-T therapy pipeline analysis market size is expected to see rapid growth in the next few years. It will grow to $4.74 billion in 2028 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to increase in blood cancer incidence rate, rise in healthcare expenditure, strong pipeline of drugs and rising focus on car-t therapy. Major trends in the forecast period include investing in the r&d for creating remodeled car-t therapy to avoid neurological side-effects, creating off-the-shelf allogeneic car-t therapy for advanced cancer treatment, manufacturing next-generation car t cells for improved treatment of high-grade glioma, investing in ai and machine learning solutions to optimize future car-t therapy, carrying out strategic collaborations to boost innovations, collaborating or acquiring competitor companies to expand car-t therapy portfolio, and investing in the car-t therapy to make it more effective. For further insights on the CAR-T therapy pipeline analysis market, request a sample here

How is the CAR-T therapy pipeline analysis market segmented?

The CAR-T therapy pipeline analysis market is segmented
1) By Type: Monotherapy, Combination Therapy
2) By Target Antigen: CD19, CD22, BCMA, Other Target Antigens
3) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications For further insights on the CAR-T therapy pipeline analysis market, request a sample here

Which region has the largest share of the CAR-T therapy pipeline analysis market? What are the other regions covered in the report?

North America was the largest region in the CAR-t therapy market in 2023. Western Europe was the second-largest region in the global CAR-T therapy market share. The regions covered in the CAR-T therapy pipeline analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the CAR-T therapy pipeline analysis market, request a sample here.

Who are the major players in the CAR-T therapy pipeline analysis market?

Major companies operating in the CAR-T therapy pipeline analysis market report are Gilead Sciences, Novartis AG, Biocon, Gracell Biotechnology Ltd, Aeon Therapeutics, CARsgen Therapeutics, Daiichi Sankyo, Otsuka Pharmaceutical, Ono Pharmaceutical, Japan Tissue Engineering, Nipro Corporation, Takeda Pharmaceutical Company, Astellas Pharma, Innovative Cellular Therapeutics, Cellular Biomedicine Group, PersonGen Biomedicine, Hebei Senlang Biotech, Adaptimmune(UK), Autolus Therapeutics, BioNTech, Cellectis, Celyad, Crescendo Biologics, GammaDelta Therapeutics, Immatics, Biocad, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Amgen, AstraZeneca, Bayer AG, Merck, Pfizer, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio Amgen, Regen BioPharma, OncoSec Medical Incorporated, Precision BioSciences, Bellicum, Sandoz AG, GlaxoSmithKline plc, Elekta, SudairPharma, Janssen, Aspen, Adcock Ingram For further insights on the CAR-T therapy pipeline analysis market, request a sample here.

What are the key trends in the CAR-T therapy pipeline analysis market?

Major trend in the CAR-T therapy pipeline analysis market - Clinical Trials And Advancements In Car-T Therapy For Multiple Myeloma. For further insights on the CAR-T therapy pipeline analysis market, request a sample here.

What are the major opportunities in the CAR-T therapy pipeline analysis market? What are the strategies for the CAR-T therapy pipeline analysis market?

For detailed insights on the major opportunities and strategies in the CAR-T therapy pipeline analysis market, request a sample here.

How does the CAR-T therapy pipeline analysis market relate to the overall economy and other similar markets?

For detailed insights on CAR-T therapy pipeline analysis market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the CAR-T therapy pipeline analysis industry?

For detailed insights on the mergers and acquisitions in the CAR-T therapy pipeline analysis industry, request a sample here.

What are the key dynamics influencing the CAR-T therapy pipeline analysis market growth? SWOT analysis of the CAR-T therapy pipeline analysis market.

For detailed insights on the key dynamics influencing the CAR-T therapy pipeline analysis market growth and SWOT analysis of the CAR-T therapy pipeline analysis industry, request a sample here.